BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27521518)

  • 1. Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis.
    Millar NL; O'Donnell C; McInnes IB; Brint E
    Semin Cell Dev Biol; 2017 Jan; 61():41-50. PubMed ID: 27521518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST2 deletion accelerates inflammatory-angiogenesis and remodeling in subcutaneous implants in mice.
    Viana CTR; Orellano LAA; Machado CT; Almeida CP; de Lazari MGT; Campos PP; Andrade SP
    Microvasc Res; 2022 Jan; 139():104277. PubMed ID: 34752815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
    Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
    Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: Effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression.
    Elsherbiny NM; Said E; Atef H; Zaitone SA
    Chem Biol Interact; 2020 Jan; 315():108897. PubMed ID: 31726037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of IL-33/ST2 Pathway in Tumorigenesis.
    Larsen KM; Minaya MK; Vaish V; Peña MMO
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of beta-blocker therapy on modulation of interleukin-33/ST2 signaling during ventricular remodeling after acute myocardial infarction.
    Xia J; Qu Y; Yin C; Xu D
    Cardiol J; 2017; 24(2):188-194. PubMed ID: 27748502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice.
    Oshio T; Komine M; Tsuda H; Tominaga SI; Saito H; Nakae S; Ohtsuki M
    J Dermatol Sci; 2017 Feb; 85(2):106-114. PubMed ID: 27839630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
    Hong J; Kim S; Lin PC
    J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Functional Roles of IL-33/ST2 Axis in Ocular Diseases.
    Qian Y; Zhang M
    Mediators Inflamm; 2020; 2020():5230716. PubMed ID: 32908451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
    Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
    Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.
    Allegra A; Innao V; Tartarisco G; Pioggia G; Casciaro M; Musolino C; Gangemi S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.
    Lopetuso LR; Scaldaferri F; Pizarro TT
    Fibrogenesis Tissue Repair; 2012 Oct; 5(1):18. PubMed ID: 23062310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
    Abd Rachman Isnadi MF; Chin VK; Abd Majid R; Lee TY; Atmadini Abdullah M; Bello Omenesa R; Osamah Ibraheem Z; Basir R
    Mediators Inflamm; 2018; 2018():5346413. PubMed ID: 29507527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?
    Aimo A; Migliorini P; Vergaro G; Franzini M; Passino C; Maisel A; Emdin M
    Int J Cardiol; 2018 Sep; 267():188-192. PubMed ID: 29793758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
    Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
    J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.